TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA · NYSE · SIC 2834: Pharmaceutical Preparations
218
SEC Filings

Business Summary

3 Item1A. Risk Factors 28 Item 1B. Unresolved Staff Comments 54 Item 1C. Cybersecurity 54 Item 2. Properties 56 Item 3. Legal Proceedings 56 Item 4. Mine Safety Disclosures 56 PART II Item 5. Market for the Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 57 Item 6. [Reserved] 58 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 59 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 85 Item...

Next Earnings

Q2 FY2026 — expected 2026-07-28

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTEVAdiscussed_in_filing Cybersecurity
topic_mentionTEVAdiscussed_in_filing Cybersecurity
topic_mentionTEVAdiscussed_in_filing Cybersecurity
topic_mentionTEVAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-032025-12-310001193125-26-034532EDGAR116K words
2025-02-052024-12-310001193125-25-020826EDGAR—
2024-02-122023-12-310001193125-24-031005EDGAR—
2023-02-102022-12-310001193125-23-031250EDGAR—
2022-02-092021-12-310001193125-22-032667EDGAR—
2021-02-102020-12-310001193125-21-036239EDGAR—
2020-02-212019-12-310001193125-20-044221EDGAR—
2019-02-192018-12-310001193125-19-043564EDGAR—
2018-02-122017-12-310001193125-18-039076EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266895EDGAR59K words
2025-07-302025-06-300001193125-25-169296EDGAR—
2025-05-072025-03-310001193125-25-114889EDGAR—
2024-11-062024-09-300001193125-24-252039EDGAR—
2024-07-312024-06-300001193125-24-189924EDGAR—
2024-05-082024-03-310001193125-24-134200EDGAR—
2023-11-092023-09-300001193125-23-274495EDGAR—
2023-08-022023-06-300001193125-23-201707EDGAR—
2023-05-102023-03-310001193125-23-140697EDGAR—
2022-11-032022-09-300001193125-22-276883EDGAR—
2022-07-272022-06-300001193125-22-203392EDGAR—
2022-05-032022-03-310001193125-22-138669EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-280001171843-26-000462EDGAR18K words
2026-01-120001171843-26-000174EDGAR—
2025-12-110001193125-25-316063EDGAR—
2025-11-050001171843-25-007000EDGAR—
2025-07-300001171843-25-004808EDGAR—
2025-06-050001193125-25-135942EDGAR—
2025-05-280001193125-25-129488EDGAR—
2025-05-220001193125-25-125071EDGAR—
2025-05-070001171843-25-002849EDGAR—
2025-01-290001171843-25-000493EDGAR—

218 total filings indexed. 187 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000818686
TickerTEVA
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedL3

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 02ea99b91dca46beb5a180eddb772a87d5f728d87878def392905daf97e1ab04
parent: bcacd995003faeeb87a9c39b8cb69105096bf8d1d87f37036713a1546e040ef5
content hash: 1b4caae09e24987c7d215bfe45ab031b7d3d1e035b87f9bd9d0d3da0dea9905f
signed: 2026-04-13T04:47:46.348Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf